These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 15988346)

  • 21. [Symptomatic therapy of Alzheimer dementia].
    Förstl H
    Wien Med Wochenschr; 2002; 152(3-4):77-80. PubMed ID: 11925776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The treatment of Alzheimer's disease: the approach from a clinical specialist in the trenches.
    Hake AM
    Semin Neurol; 2002 Mar; 22(1):71-4. PubMed ID: 12170395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pharmacological treatment in severe dementia].
    Jouanny P; Belliard S; Bentué-Ferrer D; Michel O; Allain H
    Psychol Neuropsychiatr Vieil; 2005 Mar; 3 Suppl 1():S51-5. PubMed ID: 15899605
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Drugs for the treatment of Alzheimer's disease].
    Nagura H
    Nihon Rinsho; 2004 Jan; 62 Suppl():76-80. PubMed ID: 15011324
    [No Abstract]   [Full Text] [Related]  

  • 25. [Cognitive disorders].
    Asada T
    Seishin Shinkeigaku Zasshi; 2006; 108(7):772-6. PubMed ID: 17131547
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment of the neuropsychiatric symptoms in Alzheimer's disease.
    Masterman D
    J Am Med Dir Assoc; 2003; 4(6 Suppl):S146-54. PubMed ID: 14613591
    [No Abstract]   [Full Text] [Related]  

  • 27. Psychopharmacology of noncognitive abnormal behaviors in Alzheimer's disease.
    Raskind MA
    J Clin Psychiatry; 1998; 59 Suppl 9():28-32. PubMed ID: 9720484
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological treatment of dementia.
    Schwarz S; Froelich L; Burns A
    Curr Opin Psychiatry; 2012 Nov; 25(6):542-50. PubMed ID: 22992546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological modulation of cognitive and behavioral symptoms in patients with dementia due to Alzheimer's disease.
    de Oliveira FF; Bertolucci PH; Chen ES; Smith Mde A
    J Neurol Sci; 2014 Jan; 336(1-2):103-8. PubMed ID: 24189208
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of agitation and aggression associated with Alzheimer's disease: controversies and possible solutions.
    Ballard C; Corbett A; Chitramohan R; Aarsland D
    Curr Opin Psychiatry; 2009 Nov; 22(6):532-40. PubMed ID: 19696673
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alzheimer's disease and related disorders.
    Raskind MA; Peskind ER
    Med Clin North Am; 2001 May; 85(3):803-17. PubMed ID: 11349485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psychiatric treatments: an exciting new century.
    Martin R; al Adawi S
    Hosp Med; 2000 Aug; 61(8):524-5. PubMed ID: 11045217
    [No Abstract]   [Full Text] [Related]  

  • 33. Are cholinesterase inhibitors effective in the management of the behavioral and psychological symptoms of dementia in Alzheimer's disease? A systematic review of randomized, placebo-controlled trials of donepezil, rivastigmine and galantamine.
    Rodda J; Morgan S; Walker Z
    Int Psychogeriatr; 2009 Oct; 21(5):813-24. PubMed ID: 19538824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential effects of current specific treatments on behavioral and psychological symptoms in patients with Alzheimer's disease: a 12-month, randomized, open-label trial.
    Cumbo E; Ligori LD
    J Alzheimers Dis; 2014; 39(3):477-85. PubMed ID: 24164733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized, placebo-controlled study of the efficacy and safety of sertraline in the treatment of the behavioral manifestations of Alzheimer's disease in outpatients treated with donepezil.
    Finkel SI; Mintzer JE; Dysken M; Krishnan KR; Burt T; McRae T
    Int J Geriatr Psychiatry; 2004 Jan; 19(1):9-18. PubMed ID: 14716694
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A longitudinal evaluation of behavioural and psychological symptoms of probable Alzheimer's disease.
    Eustace A; Coen R; Walsh C; Cunningham CJ; Walsh JB; Coakley D; Lawlor BA
    Int J Geriatr Psychiatry; 2002 Oct; 17(10):968-73. PubMed ID: 12325059
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Revisiting the cholinergic hypothesis of behavioral and psychological symptoms in dementia of the Alzheimer's type.
    Pinto T; Lanctôt KL; Herrmann N
    Ageing Res Rev; 2011 Sep; 10(4):404-12. PubMed ID: 21292041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of behavioral problems in Alzheimer's disease.
    Gauthier S; Cummings J; Ballard C; Brodaty H; Grossberg G; Robert P; Lyketsos C
    Int Psychogeriatr; 2010 May; 22(3):346-72. PubMed ID: 20096151
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological management of the psychiatric aspects of traumatic brain injury.
    Lee HB; Lyketsos CG; Rao V
    Int Rev Psychiatry; 2003 Nov; 15(4):359-70. PubMed ID: 15276957
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.